Dr. Abdulraheem M.s Qasem, MD

Dr. Qasem practices at AdventHealth Shawnee Mission in Shawnee Mission, Kansas, part of AdventHealth.

Dr. Qasem's NPI, 1962692368, was assigned on July 31, 2007. Dr. Qasem holds Kansas license 04-39294.

Dr. Qasem's primary practice is AdventHealth Shawnee Mission, at 9100 W 74th Street, Shawnee Mission, KS 66204 in Johnson County. The practice phone is (913) 676-2152.

Dr. Qasem's primary practice is AdventHealth Shawnee Mission in Shawnee Mission, Kansas, part of AdventHealth. Dr. Qasem is also affiliated with AdventHealth South Overland Park. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Qasem to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qasem practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Qasem's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Qasem's licenses on file in 3 states: Kansas, Michigan and Missouri.

CMS data shows 1,729 Medicare services from Dr. Qasem across 9 procedure codes in 2024, for 356 Medicare patients. Medicare paid $97,200 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 356 Medicare patients who saw Dr. Qasem in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Qasem's median patient age at 73, with 63% women.

In 2024, Dr. Qasem wrote 2,233 Medicare Part D claims for 244 patients. 86% of them were for generic drugs. CMS names the drug for 1,830 of them, across 56 drugs with 11 or more claims each, at $624,304 in total drug cost. In 2023, CMS named 1,643 claims across 53 drugs.

Dr. Qasem accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Qasem as offering telehealth.

Dmand AI links 7 papers to Dr. Qasem, published from 2015 to 2017. 2015 was the busiest year, with 2. The most frequent topics are Antimetabolites, Antineoplastic. Dr. Qasem has published most often in Am J Ther. Dr. Qasem's most frequent co-authors are Kristen Marie Strasser, MD, Mouhanna Khaled Mahmoud Abu Ghanimeh, MD and Abdelrahman Aly, MD.

CMS Open Payments shows 186 general payments to Dr. Qasem from 34 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 90% of the total. Bristol-Myers Squibb Company paid the most, $365.